RE:RE:RE:RE:RE:RE:RE:New Press Release - Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic CancerI guess the proofs in the puddin'. Let's see where the sp is tomorrow?